Rugen Therapeutics
Boston, United States · Founded 2013 · $46.5M raised
- Headquarters
- Boston, Massachusetts
- Employees
- 1–10
- Founded
- 2013
- Total Funding
- $46.5M
- Last Round
- $38.0M Series AJun 2020
- Rounds
- 2
About
Biotech company developing first-in-class small-molecule drugs for CNS disorders including autism, OCD, and treatment-resistant depression.
Summary
Rugen Therapeutics is a Biotech company based in Boston, United States, founded in 2013. It has raised $46.5M in total across 2 rounds, most recently a $38.0M Series A round in Jun 2020. Investors include F-Prime Capital and Boehringer Ingelheim Venture Fund.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2020
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...